Selective Hydrogenolysis of Glycerol to Propylene Glycol on Supported Pd Catalysts: Promoting Effects of ZnO and Mechanistic Assessment of Active PdZn Alloy Surfaces

Pd catalysts have received increasing attention for selective hydrogenolysis of glycerol to propylene glycol because of their good hydrothermal stability and high selectivity for cleavage of C–O bonds over C–C bonds. Addition of Zn can facilitate glycerol hydrogenolysis to propylene glycol on Pd surface, but the promoting role of Zn, stability of the resulting active PdZn alloys and reaction mechanism remain largely unexplored. Here, we synthesized monoclinic zirconia-supported PdZn (PdZn/m-ZrO₂) catalysts via an incipient wetness impregnation method. Glycerol hydrogenolysis turnover rates (normalized per surface Pd atom measured by H₂ chemisorption) and propylene glycol selectivity on these PdZn/m-ZrO₂ catalysts depended sensitively on their Zn/Pd molar ratios, and Zn leaching from the PdZn alloy phases led to deactivation of PdZn/m-ZrO₂. Such deactivation was efficiently inhibited when physical mixtures of Pd/m-ZrO₂ and ZnO were directly used in glycerol hydrogenolysis, leading to in situ formation of PdZn alloy layers on Pd surfaces with excellent stability and recyclability. Dependence of turnover rates on glycerol and H₂ concentrations, combined with the primary kinetic isotope effects (<i>k</i>_H<i>/k</i>_D = 2.6 at 493 K), reveals the kinetically relevant step of glycerol hydrogenolysis involving the α-C-H cleavage in 2,3-dihydroxypropanoxide intermediate to glyceraldehyde on PdZn alloys and Pd. Measured rate constants show that the transition state of α-C-H cleavage is more stable because of the stronger oxophilicity of Zn on PdZn alloys than on Pd, which thus facilitates α-C-H cleavage of the Zn-bound intermediate by adjacent Pd on PdZn alloys. Such synergy between Zn and Pd sites accounts for the observed superiority of PdZn alloys to Pd in glycerol hydrogenolysis

Additional file 1 of Giant unruptured sinus of Valsalva aneurysms causing angina pectoris

Supplementary Material

Table1_Genetically predicted circulating levels of cytokines and the risk of oral cavity and pharyngeal cancer: a bidirectional mendelian-randomization study.XLSX

Background: Epidemiological research has established associations between various inflammatory cytokines and the occurrence of oral cancer and oropharyngeal cancer (OCPC). We performed a Mendelian randomization (MR) analysis to systematically investigate the causal relationship between inflammatory cytokines and OCPC.Methods: We performed a bidirectional two-sample MR analysis using OCPC from 12 studies (6,034 cases and 6,585 controls) and genome-wide association study (GWAS) results for 41 serum cytokines from 8,293 Finns, respectively. Inverse variance weighting was used as the primary MR method and four additional MR methods (MR Egger, Weighted median, Simple mode, Weighted mode) were used to examine genetic associations between inflammatory traits and OCPC, and Cochran’s Q test, MR-Egger intercept, leave-one-out analysis, funnel plot, and multivariate MR (MVMR) analysis were used to assess the MR results.Results: The results suggested a potential association between high gene expression of Macrophage inflammatory protein-1α (MIP1α/CCL3) and an increased risk of OCPC (Odds Ratio (OR): 1.71, 95% Confidence Interval (CI): 1.09–2.68, p = 0.019). Increasing the expression levels of the interleukin-7 (IL-7) gene by 1 standard deviation reduced the risk of OCPC (OR: 0.64, 95%CI: 0.48–0.86, p = 0.003). In addition, multivariate Mendelian randomization analysis also showed the same results (MIP1α/CCL3, OR: 1.002, 95% CI: 0.919–1.092, p = 0.044; IL-7, OR: 0.997, 95% CI: 0.994–0.999, p = 0.011). Conversely, there was a positive correlation between genetic susceptibility to OCPC and an increase in Interleukin-4 (IL-4) (OR: 1.04, 95%CI: 1.00–1.08, p = 0.027).Conclusion: Our study systematically assessed the association between inflammatory cytokines and the risk of OCPC. We identified two upstream regulatory factors (IL-7 and CCL3) and one downstream effector factor (IL-4) that were associated with OCPC, offering potential avenues for the development of novel treatments.</p

Image1_Genetically predicted circulating levels of cytokines and the risk of oral cavity and pharyngeal cancer: a bidirectional mendelian-randomization study.pdf

Background: Epidemiological research has established associations between various inflammatory cytokines and the occurrence of oral cancer and oropharyngeal cancer (OCPC). We performed a Mendelian randomization (MR) analysis to systematically investigate the causal relationship between inflammatory cytokines and OCPC.Methods: We performed a bidirectional two-sample MR analysis using OCPC from 12 studies (6,034 cases and 6,585 controls) and genome-wide association study (GWAS) results for 41 serum cytokines from 8,293 Finns, respectively. Inverse variance weighting was used as the primary MR method and four additional MR methods (MR Egger, Weighted median, Simple mode, Weighted mode) were used to examine genetic associations between inflammatory traits and OCPC, and Cochran’s Q test, MR-Egger intercept, leave-one-out analysis, funnel plot, and multivariate MR (MVMR) analysis were used to assess the MR results.Results: The results suggested a potential association between high gene expression of Macrophage inflammatory protein-1α (MIP1α/CCL3) and an increased risk of OCPC (Odds Ratio (OR): 1.71, 95% Confidence Interval (CI): 1.09–2.68, p = 0.019). Increasing the expression levels of the interleukin-7 (IL-7) gene by 1 standard deviation reduced the risk of OCPC (OR: 0.64, 95%CI: 0.48–0.86, p = 0.003). In addition, multivariate Mendelian randomization analysis also showed the same results (MIP1α/CCL3, OR: 1.002, 95% CI: 0.919–1.092, p = 0.044; IL-7, OR: 0.997, 95% CI: 0.994–0.999, p = 0.011). Conversely, there was a positive correlation between genetic susceptibility to OCPC and an increase in Interleukin-4 (IL-4) (OR: 1.04, 95%CI: 1.00–1.08, p = 0.027).Conclusion: Our study systematically assessed the association between inflammatory cytokines and the risk of OCPC. We identified two upstream regulatory factors (IL-7 and CCL3) and one downstream effector factor (IL-4) that were associated with OCPC, offering potential avenues for the development of novel treatments.</p